Maspin expression in gastrointestinal stromal tumors

World Journal of Surgical Oncology

Volumn 8, Issue , 2010, Pages

  Adim, Saduman B ^a   Filiz, Gulaydan ^a   Kanat, Ozkan ^a   Yerci, Omer ^a   Ozguc, Halil ^a   Aytac, Berna ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

MASPIN; SERINE PROTEINASE INHIBITOR; SERPIN B5; SERPIN-B5; TUMOR MARKER;

ACUTE PANCREATITIS; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER LOCALIZATION; CANCER RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HIGH RISK PATIENT; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR GROWTH; CANCER STAGING; DISEASE COURSE; ENZYME IMMUNOASSAY; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; DISEASE PROGRESSION; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SERPINS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77952309178     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-8-22     Document Type: Article

References (35)

1. Stamatakos M, Douzinas E, Stefanaki C, Safioleas P, Polyzou E, Levidou G, Safioleas M. Gastrointestinal stromal tumor. World J Surg Oncol 2009, 7:61.
2. Duffaud F, Blay JY. Gastrointestinal stromal tumors: biology and treatment. Oncology 2003, 65:187-197.
3. Deitos AP. The reapraisal of gastrointestinal stromal tumors: from stout to the KIT revolution. Virchows Arch 2003, 442:421-428.
4. Connolly EM, Gaffney E, Reynolds JV. Gastrointestinal stromal tumors. British Journal of Surgery 2003, 90:1178-1186.
5. Miettinen M, Lasota J. Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arc 2001, 438:1-12.
6. Fletcher CDM, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Human Pathology 2002, 33:459-465.
7. Date RS, Stylianides NA, Pursnani KG, Ward JB, Mughal MM. Management of gastrointestinal stromal tumours in the Imatinib era: a surgeon's perspective. World J Surg Oncol 2008, 18(6):77.
8. Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddell RH. Interstitial cells of cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol 1999, 23:377-389.
9. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994, 263:526-529.
10. Bailey CM, Khalkhali-Ellis Z, Seftor EA, Hendrix MJ. Biological functions of maspin. J Cell Physiol 2006, 209:617-624.
11. Schaefer JS, Zhang M. Role of maspin in tumor metastasis and angiogenesis. Curr Mol Med 2003, 3:653-658.
12. Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ, Sager R. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci USA 1996, 93:11669-11674.
13. Zhang M, Volpert O, Shi YH, Bouck N. Maspin is an angiogenesis inhibitor. Nat Med 2000, 6:196-199.
14. Jiang N, Meng Y, Zhang S, Mensah-Osman E, Sheng S. Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene 2002, 21:4089-4098.
15. Pemberton PA, Tipton AR, Pavloff N, Smith J, Ericson JR, Mouchabeck ZM, Kiefer MC. Maspin is an intracellular serpin that partitions into secretory vesicles and present at the cell surface. J Histochem Cytochem 1997, 45:1697-1706.
16. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R. Maspin a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994, 263:526-529.
17. De Lima Navarro R, Trierveiler Martins M, Cavalcanti de Araujo V. Maspin expression in normal and neoplastic salivary gland. J Oral Pathol Med 2004, 33:435-440.
18. Reis-Filho JS, Torio B, Albergaria A, Schmitt FC. Maspin expression in normal skin and usual cutaneous carcinomas. Virchows Arch 2002, 441:551-558.
19. Nakagawa M, Katakura H, Adachi M, Takenaka K, Yanagihara K, Otake Y, Wada H, Tanaka F. Maspin expression and its clinical significance in non-small cell lung cancer. Ann Surg Oncol 2006, 13:1517-1523.
20. Boltze C. Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis. Pathol Res Pract 2005, 200:783-790.
21. Ito R, Nakayama H, Yoshida K, Oda N, Yasui W. Loss of maspin expression is associated with development and progression of gastric carcinoma with p53 abnormality. Oncol Rep 2004, 12:985-990.
22. Friedrich MG, Toma MI, Petri S, Cheng JC, Hammerer P, Erbersdobler A, Huland H. Expression of maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis. Eur Urol 2004, 45:737-743.
23. Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, Khalkhali-Ellis Z, Arbour N, Seftor EA, Hendrix MJC. The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 2002, 8:2924-2932.
24. Maass N, Hojo T, Ueding M, Luttges J, Kloppel G, Jonat W, Nagasaki K. Expression of the tumor suppressor gene Maspin in human pancreatic cancers. Clin Cancer Res 2001, 7:812-817.
25. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, Misek DE, Hanash S. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003, 63:2649-2657.
26. DeClerck YA, Mercurio AM, Stack MS, Chapman HA, Zutter MM, Muschel RJ, Raz A, Matrisian LM, Sloane BF, Noel A, Hendrix MJ, Coussens L, Padarathsingh M. Proteases, extracellular matrix and cancer. American Journal of Pathology 2004, 164:1131-1139.
27. Shi HY, Liang R, Templeton N, Zhang M. Characterization and systemic treatment of maspin in a breast metastasis model. Molecular Therapy 2002, 5:755-761.
28. Maass N, Biallek M, Rösel F, Schem C, Ohike N, Zhang M, Jonat W, Nagasaki K. Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. Biochem Biophys Res Commun 2002, 297:125-128.
29. EI C, JR Y. Maspin and tumor metastasis. IUBMB Life 2006, 58:25-29.
30. Yu M, Zheng H, Tsuneyama K, Takahashi H, Nomoto K, Xu H, Takano Y. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression. Hum Pathol 2007, 38:1248-55.
31. Ngamkitidechakul C, Burke JM, O'Brien WJ, Twining SS. Maspin: synthesis by human cornea and regulation of in vitro stromal cell adhesion to extracellular matrix. Invest Ophthalmol Vis Sci 2001, 42:3135-3141.
32. Wang DL, Wang YF, Shi GS, Huang H. Correlation of hTERT expression to maspin and bFGF expression and their significance inglioma. Ai Zheng 2007, 26:601-606.
33. Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E, Srivastava S. P53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 2000, 275:6051-6054.
34. Yalcinkaya U, Yerci O, Koc EU. Significance of p53 expression in gastrointestinal stromal tumors. Hepatogastroenterology 2007, 54:140-143.
35. Pauser U, Schmedt Auf der Günne N, Klöppel G, Merz H, Feller AC. P53 expression is significantly correlated with high risk of malignancy and epithelioid differentiation in GISTs. An immunohistochemical study of 104 cases. BMC Cancer 2008, 8:204-210.